Propranolol restores susceptibility of XDR Gram-negative pathogens to meropenem and Meropenem combination has been evaluated with either tigecycline or amikacin
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Propranolol restores susceptibility of XDR Gram-negative pathogens to meropenem and Meropenem combination has been evaluated with either tigecycline or amikacin ; volume:23 ; number:1 ; day:22 ; month:7 ; year:2023 ; pages:1-17 ; date:12.2023
BMC microbiology ; 23, Heft 1 (22.7.2023), 1-17, 12.2023
- Creator
-
Mabrouk, Samar S.
Abdellatif, Ghada R.
Zaid, Ahmed S. Abu
Aboshanab, Khaled M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12866-023-02934-6
- URN
-
urn:nbn:de:101:1-2023102609423487485050
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mabrouk, Samar S.
- Abdellatif, Ghada R.
- Zaid, Ahmed S. Abu
- Aboshanab, Khaled M.
- SpringerLink (Online service)
Other Objects (12)
Meropenem: continuous or extended infusion?
The Place of Meropenem–Vaborbactam in the Management of Carbapenem-Resistant Gram-Negative Infections
Population pharmacokinetics of meropenem in critically ill patients
In-vitro-Untersuchungen mit Meropenem - einem neuen Carbapenem-Derivat
Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections
Die Pharmakokinetik von Meropenem bei Patienten mit schweren Infektionen
Magnolol restores the activity of meropenem against NDM-1-producing Escherichia coli by inhibiting the activity of metallo-beta-lactamase
Pharmakokinetik von Linezolid und Meropenem bei Intensivpatienten mit kontinuierlicher Nierenersatztherapie
Meropenem-induced pancytopenia in a preterm neonate: a case report
Comparison between meropenem and ceftolozane/tazobactam: possible influence of CRRT
In-vitro-Aktivität des neuen Carbapenem-Antibiotikums Meropenem gegenüber pathogenen Bakterien
Cerebrospinal fluid penetration of very high-dose meropenem : a case report
Meropenem: continuous or extended infusion?
The Place of Meropenem–Vaborbactam in the Management of Carbapenem-Resistant Gram-Negative Infections
Population pharmacokinetics of meropenem in critically ill patients
In-vitro-Untersuchungen mit Meropenem - einem neuen Carbapenem-Derivat
Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections
Die Pharmakokinetik von Meropenem bei Patienten mit schweren Infektionen
Magnolol restores the activity of meropenem against NDM-1-producing Escherichia coli by inhibiting the activity of metallo-beta-lactamase
Pharmakokinetik von Linezolid und Meropenem bei Intensivpatienten mit kontinuierlicher Nierenersatztherapie
Meropenem-induced pancytopenia in a preterm neonate: a case report
Comparison between meropenem and ceftolozane/tazobactam: possible influence of CRRT
In-vitro-Aktivität des neuen Carbapenem-Antibiotikums Meropenem gegenüber pathogenen Bakterien
Cerebrospinal fluid penetration of very high-dose meropenem : a case report
Meropenem: continuous or extended infusion?
The Place of Meropenem–Vaborbactam in the Management of Carbapenem-Resistant Gram-Negative Infections
Population pharmacokinetics of meropenem in critically ill patients
In-vitro-Untersuchungen mit Meropenem - einem neuen Carbapenem-Derivat
Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections
Die Pharmakokinetik von Meropenem bei Patienten mit schweren Infektionen
Magnolol restores the activity of meropenem against NDM-1-producing Escherichia coli by inhibiting the activity of metallo-beta-lactamase
Pharmakokinetik von Linezolid und Meropenem bei Intensivpatienten mit kontinuierlicher Nierenersatztherapie
Meropenem-induced pancytopenia in a preterm neonate: a case report
Comparison between meropenem and ceftolozane/tazobactam: possible influence of CRRT
In-vitro-Aktivität des neuen Carbapenem-Antibiotikums Meropenem gegenüber pathogenen Bakterien